title: Extracorporeal immunomodulation in patients with hepatocellular carcinoma with lymphokine activated killer cells.
authors.affiliation: First Department of Internal Medicine, Kochi Medical School, Japan.
authors.forename: T
authors.initials: T
authors.lastname: Saibara
authors.forename: M
authors.initials: M
authors.lastname: Fujikawa
authors.forename: S
authors.initials: S
authors.lastname: Iwamura
authors.forename: Y
authors.initials: Y
authors.lastname: Matsuura
authors.forename: E
authors.initials: E
authors.lastname: Ido
authors.forename: H
authors.initials: H
authors.lastname: Sakaeda
authors.forename: A
authors.initials: A
authors.lastname: Tomita
authors.forename: Y
authors.initials: Y
authors.lastname: Matsunaga
authors.forename: T
authors.initials: T
authors.lastname: Maeda
authors.forename: S
authors.initials: S
authors.lastname: Onishi
mesh_terms: D000368:Aged; D006528:Carcinoma, Hepatocellular / Q000276:immunology / Q000628:therapy*; D002986:Clinical Trials as Topic; D003602:Cytotoxicity, Immunologic; D005260:Female; D006801:Humans; D007116:Immunization, Passive; D007371:Interferon-gamma / Q000096:biosynthesis; D007376:Interleukin-2 / Q000627:therapeutic use; D015979:Killer Cells, Lymphokine-Activated / Q000276:immunology*; D007694:Killer Cells, Natural / Q000276:immunology; D008113:Liver Neoplasms / Q000276:immunology / Q000628:therapy*; D008297:Male; D008875:Middle Aged
chemical_list: D007376:Interleukin-2; D007371:Interferon-gamma